You are here:
29 Nov 2019 Investor Update
Victorian medicines accelerator, BioCurate, is partnering with Takeda Pharmaceutical Company Limited to expedite the development of new therapeutics and drugs.
14 Nov 2019 Investor Update
Australia’s capital, Canberra, is set for a large-scale renewable-energy auction to guarantee its 100 per cent renewables target into the mid-2020s.
7 Nov 2019 Investor Update
Malaysian engineering, property and infrastructure company Gamuda Berhad has acquired a 50% share of Martinus Rail, a New South Wales-based railway infrastructure firm.
1 Nov 2019 Investor Update
Korea’s Yuhan Corporation announced on 1 November that it has signed a Memorandum of Understanding (MoU) with one of Australia’s oldest research institutions, the 104-year-old Walter and Eliza Hall In ...
18 Oct 2019 Investor Update
Singapore-based, The Ascott Limited (Ascott), is investing A$202.2 million in a new, 48-storey freehold serviced residence in North Sydney’s CBD. Ascott is one of the world’s largest international lod ...
Major US healthcare provider HMS is investing US$7.5 million in Australian digital health company, MedAdvisor, in a move that could help tackle the global issue of patient non-adherence to medications ...
30 Aug 2019 Investor Update
Companies with major investments in Australia can quickly bring skilled employers into Australia to fill temporary shortages, after implementation of a change to the Accredited Sponsor Scheme for the ...
29 Aug 2019 Investor Update
A new global partnership between Japanese artificial intelligence (AI) specialists, a US scanner manufacturer and Australian clinicians could dramatically improve diagnoses of a common, fatal brain co ...
27 Aug 2019 Investor Update
The US-owned Hyatt hotel chain will return to South Australia after a 15-year hiatus, with plans for a major new 295-room property in Pirie Street, in Adelaide’s CBD.
15 Aug 2019 Investor Update
Sunbirds, a Toulouse-based startup has set up an office, assembly workshop and maintenance centre in Brisbane, Queensland. The office provides drone packages and drone-as-a-service solutions to survey ...
South Korean pharmaceuticals and chemicals company, Yuhan Co, Ltd (Yuhan), is setting up a permanent clinical presence in South Australia, reports the Korea Herald.
5 Aug 2019 Investor Update
French pharmaceutical company Servier Group, through its Australian subsidiary, and Australia’s BioCurate will share commercial and scientific expertise to accelerate the discovery of new therapeutics ...
29 Jul 2019 Investor Update
California-based PharmaCyte Biotech and the University of Technology Sydney (UTS) have signed a research agreement to develop a new version of Melligen cells that can potentially express higher levels ...
26 Jul 2019 Investor Update
Brisbane City Council selected the startup from nine other global and local competitors.
20 Jun 2019 Investor Update
Seoul-based genome specialist, Macrogen, has agreed a A$4.1 million investment in the Queensland microbiome testing and bioinformatics company, Microba.
19 Jun 2019 Investor Update
Austrade has launched a digital health website showcasing Australia as an ideal location for developing, testing and launching the next generation of digital medical technologies.
13 Jun 2019 Investor Update
San Diego-based biotechnology company, Organovo Holdings (Organovo), has announced a tie up with a Melbourne research institute to help develop regenerative medicine in Australia.
12 Jun 2019 Investor Update
Chinese genome sequencing company, BGI Genomics (BGI), and Australian health-data expert, Pryzm Health (Pryzm) have announced a collaboration designed to bring genome-related precision health services ...
14 May 2019 Investor Update
The Daydream Island resort in the Whitsunday Islands has reopened after a A$120 million rebuild by owners, China Capital Investment Group. The island and its iconic ‘living reef’ resort were badly dam ...
17 Apr 2019 Investor Update
Praxis Precision Medicines has chosen Australia to be its Asia-Pacific headquarters and research and development (R&D) centre.